Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000

被引:87
作者
Bennett, K [1 ]
Kabir, Z
Unal, B
Shelley, E
Critchley, J
Perry, I
Feely, J
Capewell, S
机构
[1] St James Univ Hosp, Trinity Ctr Hlth Sci, Dept Pharmacol & Therapeut, Dublin 8, Ireland
[2] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3BX, Merseyside, England
[3] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland
[4] Liverpool Sch Trop Med & Hyg, Int Hlth Res Grp, Liverpool, Merseyside, England
[5] Hawkins House, Dept Hlth & Children, Dublin, Ireland
[6] Dokuz Eylul Univ, Fac Med, Dept Publ Hlth, Izmir, Turkey
关键词
D O I
10.1136/jech.2005.038638
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objectives: To examine the proportion of the recent decline in coronary heart disease (CHD) deaths in Ireland attributable to ( a) "evidence based'' medical and surgical treatments, and (b) changes in major cardiovascular risk factors. Design setting: IMPACT, a previously validated model, was used to combine and analyse data on the use and effectiveness of specific cardiology treatments and risk factor trends, stratified by age and sex. The main data sources were published trials and meta-analyses, official statistics, clinical audits, and observational studies. Results: Between 1985 and 2000, CHD mortality rates in Ireland fell by 47% in those aged 25 - 84. Some 43.6% of the observed decrease in mortality was attributed to treatment effects and 48.1% to favourable population risk factor trends; specifically declining smoking prevalence (25.6%), mean cholesterol concentrations (30.2%), and blood pressure levels (6.0%), but offset by increases in adverse population trends related to obesity, diabetes, and inactivity (-13.8%). Conclusions: The results emphasise the importance of a comprehensive strategy that maximises population coverage of effective treatments, and that actively promotes primary prevention, particularly tobacco control and a cardioprotective diet.
引用
收藏
页码:322 / 327
页数:6
相关论文
共 37 条
  • [1] *AS PAC COH STUD C, 2004, INT J EPIDEMIOL, V33, P1
  • [2] MEDICAL-MANAGEMENT AND THE DECLINE IN MORTALITY FROM CORONARY HEART-DISEASE
    BEAGLEHOLE, R
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6512): : 33 - 35
  • [3] Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002
  • [4] UNCERTAINTY IN THE ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES - THE ROLE OF SENSITIVITY ANALYSIS
    BRIGGS, A
    SCULPHER, M
    BUXTON, M
    [J]. HEALTH ECONOMICS, 1994, 3 (02) : 95 - 104
  • [5] Increasing the impact of cardiological treatments - How best to reduce deaths
    Capewell, S
    Pell, JP
    Morrison, C
    McMurray, J
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (19) : 1386 - 1392
  • [6] Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994
    Capewell, S
    Morrison, CE
    McMurray, JJ
    [J]. HEART, 1999, 81 (04) : 380 - 386
  • [7] Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993
    Capewell, S
    Beaglehole, R
    Seddon, M
    McMurray, J
    [J]. CIRCULATION, 2000, 102 (13) : 1511 - 1516
  • [8] Creagh D, 2002, Ir Med J, V95, P298
  • [9] Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999
    Critchley, J
    Liu, J
    Zhao, D
    Wei, W
    Capewell, S
    [J]. CIRCULATION, 2004, 110 (10) : 1236 - 1244
  • [10] Mortality risk reduction associated with smoking cessation in patients with coronary heart disease - A systematic review
    Critchley, JA
    Capewell, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (01): : 86 - 97